Approximately 1.24 million people are diagnosed with blood cancer globally each year, making up about 6% of all cancer cases. This number continues to rise steadily. Fortunately, advancements in medical technology and the expertise of healthcare professionals in India have led to improved survival rates for those affected by blood cancer. Receiving a blood cancer diagnosis can be overwhelming, but with the right guidance and timely intervention, many patients can be successfully treated.
You too can become a blood cancer survivor by following the appropriate treatment plan tailored to your specific cancer stage. Blood cancers impact the blood, bone marrow, and lymphatic system, causing disruptions in cell production within the bone marrow. This leads to the excessive production of abnormal white blood cells, which disrupts the formation of other blood cells and results in various symptoms. Additionally, blood cancer cells can spread to other parts of the body, manifesting as tumors.
The good news is that blood cancer treatment has become increasingly accessible and has advanced significantly. Chronic, slow-progressing blood cancers may be managed with regular monitoring and oral medications, while aggressive and acute cases may require more intensive treatments such as chemotherapy, radiation, or stem cell transplantation. Ultimately, the recommended treatment will depend on the severity of the cancer and the individual patient’s needs and preferences.
Blood cancers, also known as hematologic cancers, arise from disruptions in blood cell production, which normally occurs in the bone marrow—the spongy tissue at the center of bones. Abnormalities in hematopoiesis lead to the growth of dysfunctional blood cells, including an increase in immature and poorly developed white blood cells. All blood cells originate from stem cells; red blood cells transport oxygen, white blood cells combat infections, and platelets facilitate blood clotting to stop bleeding. Blood cancer primarily affects the bone marrow, highlighting its critical role in overall health.
What are the different types of blood cancer?
Blood Cancer Types:
Blood cancer primarily falls into three main categories based on the type of cells affected:
- Leukemia: This type of cancer originates from white blood cells during their formation. In leukemia, stem cells in the bone marrow produce an excessive number of abnormal white blood cells that are ineffective, leading to a weakened immune system. This condition can also result in lower levels of red blood cells and platelets. Leukemia is classified based on the cells involved:
- Lymphocytic leukemia: This affects lymphocytes, where an overproduction of lymphoid stem cells leads to abnormal lymphocytes.
- Myeloid leukemia: This type impacts myeloid cells, causing an abnormal increase in myeloid cells and the formation of dysfunctional myeloblasts. This results in a surplus of abnormal white blood cells alongside a decrease in red blood cells and platelets.
- Both lymphocytic and myeloid leukemia can be acute, progressing rapidly, or chronic, developing over months or even years. The specific types include:
- Acute lymphocytic leukemia
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Chronic myeloid leukemia
- Leukemia tends to affect men more than women, and the age demographics vary: acute lymphocytic leukemia is most common in children and young adults, while chronic lymphocytic leukemia is typically seen in older adults. Acute myeloid leukemia can occur at any age, and chronic lymphocytic leukemia is generally diagnosed in middle-aged individuals.
- Lymphoma: This cancer begins in the lymphocytes, where they become abnormal and multiply uncontrollably, creating more dysfunctional cells. Lymphoma is divided into two main types:
- Hodgkin lymphoma: Here, the abnormal cells spread uniformly from one lymph node to another.
- Non-Hodgkin lymphoma: This type spreads in a more irregular pattern.
- Myeloma (Multiple Myeloma): Myeloma develops due to issues in the bone marrow’s production of plasma cells, which are crucial for generating antibodies that combat infections. In this condition, plasma cells proliferate abnormally, leading to the production of monoclonal antibodies that are ineffective against infections. This causes a deficiency of immune cells and antibodies, leaving myeloma patients vulnerable to infections. The disease also results in decreased levels of red blood cells and platelets, leading to anemia and increased bleeding risks. Myeloma cells can accumulate throughout the body, earning the term “multiple myeloma.” These cells can damage surrounding bones, increasing calcium levels in the blood and impaired kidney function.
What is the cost of blood cancers treatment in India?
Below is a table summarizing estimated costs of common blood cancer treatments in India, both in Indian Rupees (INR) and US Dollars (USD).
Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
Chemotherapy | ₹1,00,000 – ₹5,00,000 | $1,200 – $6,000 |
Stem Cell Transplant | ₹10,00,000 – ₹25,00,000 | $12,000 – $30,000 |
Radiation Therapy | ₹1,50,000 – ₹6,00,000 | $1,800 – $7,200 |
Targeted Therapy | ₹2,50,000 – ₹10,00,000 | $3,000 – $12,000 |
Immunotherapy | ₹5,00,000 – ₹15,00,000 | $6,000 – $18,000 |
Cost Comparison Across Major Indian Cities
Treatment costs vary across metropolitan cities in India, depending on the hospital, location, and expertise available. The following table provides a comparison of estimated blood cancer treatment costs across five key cities:
City | Chemotherapy (INR) | Stem Cell Transplant (INR) | Radiation Therapy (INR) | Targeted Therapy (INR) | Immunotherapy (INR) |
Delhi | ₹1,20,000 – ₹4,00,000 | ₹12,00,000 – ₹20,00,000 | ₹1,80,000 – ₹5,50,000 | ₹3,00,000 – ₹8,00,000 | ₹5,50,000 – ₹12,00,000 |
Mumbai | ₹1,50,000 – ₹4,50,000 | ₹14,00,000 – ₹22,00,000 | ₹2,00,000 – ₹6,00,000 | ₹3,50,000 – ₹9,00,000 | ₹6,00,000 – ₹13,00,000 |
Bengaluru | ₹1,00,000 – ₹3,50,000 | ₹10,00,000 – ₹18,00,000 | ₹1,50,000 – ₹5,00,000 | ₹2,50,000 – ₹7,00,000 | ₹5,00,000 – ₹11,00,000 |
Chennai | ₹1,20,000 – ₹3,80,000 | ₹11,00,000 – ₹20,00,000 | ₹1,60,000 – ₹5,50,000 | ₹3,00,000 – ₹8,50,000 | ₹5,50,000 – ₹12,50,000 |
Kolkata | ₹1,10,000 – ₹3,00,000 | ₹10,00,000 – ₹17,00,000 | ₹1,40,000 – ₹4,50,000 | ₹2,80,000 – ₹7,50,000 | ₹4,50,000 – ₹11,00,000 |
How long is the stay period in India and at the hospital for Blood Cancer Treatment?
The hospital stay for blood cancer treatment in India can vary significantly depending on the type and stage of blood cancer and the specific treatment protocol (such as chemotherapy, stem cell transplant, or targeted therapy). For initial chemotherapy cycles, patients may require hospitalization for 3-7 days per cycle. If a stem cell transplant is planned, the hospital stay could extend to 3-4 weeks or longer due to the need for close monitoring and supportive care. After discharge, it is often recommended that patients stay in India for an additional 2-4 weeks for follow-up visits and monitoring for any complications, such as infection or issues related to recovery.